The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A retrospective study from the Royal Marsden Hospital (RMH) of patients with malignant perivascular epithelioid cell tumors (PEComa) receiving treatment with sirolimus (SI) or temsirolimus (TSI).
Joanna Vitfell Pedersen
No relevant relationships to disclose
Charlotte Benson
No relevant relationships to disclose
Nina Tunariu
No relevant relationships to disclose
Scott Mitchell
No relevant relationships to disclose
Cyril Fisher
No relevant relationships to disclose
Khin Thway
No relevant relationships to disclose
James M. G. Larkin
No relevant relationships to disclose
Michelle Scurr
No relevant relationships to disclose
Ian Robert Judson
No relevant relationships to disclose